Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George Atiee, MD
December 12, 2022 10:00 ET
|
Dr. Vince Clinical Research
Overland Park, KS., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR) announced the addition of highly experienced investigator George J. Atiee, M.D. to the medical team at its...
Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial
November 09, 2022 10:00 ET
|
Dr. Vince Clinical Research
Overland Park, KS., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR), a world-class early phase contract research organization (CRO) specializing in the conduct of Phase I...
Dr. Vince Clinical Research Announces Addition of Principal Investigator Steven Hull, M.D.
December 07, 2021 13:00 ET
|
Dr. Vince Clinical Research
Overland Park, KS., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR) added depth to its medical team with the addition of industry veteran Steven Hull, M.D., FCCP, FAASM, as a...
Industry Veteran Launches New CRO, Dr. Vince Clinical Research, and Begins Headquarters Construction
October 26, 2021 11:00 ET
|
Dr. Vince Clinical Research
Overland Park, KS., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Dr. Brad Vince announced he has founded a new clinical research organization and is building a cutting-edge headquarters and research complex in...